A new study published in the New England Journal of Medicine, finds that antibodies to SARS-CoV-2 infection lasted for at least 4 months after initial infection, a large serosurvey in Iceland found. Although the study didn’t go into if the antibodies adequate to prevent re-infection.
Our results indicate that antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis. We estimate that the risk of death from infection was 0.3% and that 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by qPCR.” -New England Journal of Medicine
More confirmation that immunity is possible. A lot more effort should be put into treating the symptoms early to reduce the damage to the body and reducing the fatality rate than relying on a vaccine to prevent spreading it. So far the recovery rate is around 98% and obviously evidence shows they are now well armed with antibodies to fight further infections and do not need vaccination.”
Read the study at:
Humoral Immune Response to SARS-CoV-2 in Iceland